Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Multiple Primary

Explore clinical trials studying Neoplasms, Multiple Primary. Study availability and eligibility vary by location and protocol.

286 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Multiple Primary trial results

Not Yet Recruiting

Institution of an Italian Multicenter Database of Patients With Multiple Endocrine Neoplasia Type 1 (MENNET1 Database)

NCT06790251

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +7 more
Locations
  • Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, UO di Medicina Interna-Endocrinologia AOU San Luigi Gonzaga Orbassano, Torino, Italy
  • Ambulatorio Tumori Neuro-Endocrini, Unità Operativa Complessa di Oncologia Medica Universitaria, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari Bari, Italy
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, UO Pediatria, Programma di Malattie Endocrino-Metaboliche Bologna, Italy
  • UOC Endocrinologia e Prevenzione e Cura del Diabete, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), Alma Mater Studiorum Università di Bologna Bologna, Italy
View all 33 locations
View Trial Details
Completed

Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

NCT05631795

Conditions
Advanced Breast Cancer, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, +8 more
Locations
  • Novartis Investigative Site Guwahati, Assam, India
  • Novartis Investigative Site Surat, Gujarat, India
  • Novartis Investigative Site Thalassery, Kerala, India
  • Novartis Investigative Site Trivandrum, Kerala, India
View Trial Details

Related conditions